No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DRTS Alpha Tau Medical
- 2.070
- -0.030-1.43%
Close Jul 22 16:00 ET
- 2.060
- -0.010-0.47%
Post 16:07 ET
144.48MMarket Cap-5048P/E (TTM)
2.170High2.060Low28.39KVolume2.100Open2.100Pre Close59.37KTurnover0.06%Turnover RatioLossP/E (Static)69.80MShares4.25052wk High1.83P/B107.37MFloat Cap1.75052wk Low--Dividend TTM51.87MShs Float20.650Historical High--Div YieldTTM5.24%Amplitude1.750Historical Low2.090Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Alpha Tau Medical Publishes Pooled Analysis Of Alpha DaRT Therapy In Journal *Cancers*; Data From 4 International Trials Show Nearly 100% Overall Response Rate And 89% Complete Response Rate In Treated Lesions
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9
H.C. Wainwright analyst Yi Chen maintains $Alpha Tau Medical(DRTS.US)$ with a buy rating, and maintains the target price at $9.According to TipRanks data, the analyst has a success rate of 27.0% and a
Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference
Alpha Tau to Present at the Jefferies Global Healthcare Conference
6-K: Report of foreign private issuer (related to financial reporting)
Press Release: Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT(TM), reported first quarter 2024 financial results and provided a corporate update.
Comments
$Alpha Tau Medical(DRTS.US$
NEWS
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
NEWS
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
$Alpha Tau Medical(DRTS.US$
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals(DAWN.US$
- Co on Sunday Announced Results of Relapsed Pediatric Low-Grade Glioma Show 64% Overall Response Rate. recently added. Looking for more above $18.
$Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares(DRIP.US$
...
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals(DAWN.US$
- Co on Sunday Announced Results of Relapsed Pediatric Low-Grade Glioma Show 64% Overall Response Rate. recently added. Looking for more above $18.
$Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X Shares(DRIP.US$
...
2
$Blue Hat Interactive Entertainment Technology(BHAT.US$
- Blue Hat Interactive Terminates Previously Proposed Shelf Takedown Offering
$Cardiff Oncology(CRDF.US$
- stock moving higher with other health care stocks. Adding above $2.5
$Microvision(MVIS.US$
- MicroVision Unveiled New MAVIN Lidar Product Line to Enable High Speed Highway Safety FeaturesMicroVision, Inc. Stock still in uptrend.
$Alpha Tau Medical(DRTS.US$
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Ma...
- Blue Hat Interactive Terminates Previously Proposed Shelf Takedown Offering
$Cardiff Oncology(CRDF.US$
- stock moving higher with other health care stocks. Adding above $2.5
$Microvision(MVIS.US$
- MicroVision Unveiled New MAVIN Lidar Product Line to Enable High Speed Highway Safety FeaturesMicroVision, Inc. Stock still in uptrend.
$Alpha Tau Medical(DRTS.US$
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Ma...
1
Gainers:
• $Aura Biosciences(AURA.US$ +13.9% (reports topline data from study of AU-011)
• $Hyzon Motors(HYZN.US$ +8.2% (to collaborate with $Schlumberger(SLB.US$ in decarbonizing oil & gas field operations with high-power fuel cells)
• $Apogee Enterprises(APOG.US$ +6.3% (In reaction to earnings/guidance)
• $GMS Inc(GMS.US$ +6% (In reaction to earnings/guidance)
• $Darden Restaurants(DRI.US$ +4.2% (In reaction to earnings/gui...
• $Aura Biosciences(AURA.US$ +13.9% (reports topline data from study of AU-011)
• $Hyzon Motors(HYZN.US$ +8.2% (to collaborate with $Schlumberger(SLB.US$ in decarbonizing oil & gas field operations with high-power fuel cells)
• $Apogee Enterprises(APOG.US$ +6.3% (In reaction to earnings/guidance)
• $GMS Inc(GMS.US$ +6% (In reaction to earnings/guidance)
• $Darden Restaurants(DRI.US$ +4.2% (In reaction to earnings/gui...
9
2
$Microvision(MVIS.US$
- MicroVision Unveiled New MAVIN Lidar Product Line to Enable High Speed Highway Safety FeaturesMicroVision, Inc. Stock still in uptrend.
$Alpha Tau Medical(DRTS.US$
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals(DAWN.US$
- Co on Sunday Announced Results of Relaps...
- MicroVision Unveiled New MAVIN Lidar Product Line to Enable High Speed Highway Safety FeaturesMicroVision, Inc. Stock still in uptrend.
$Alpha Tau Medical(DRTS.US$
- Alpha Tau Announces Receipt of Radioactive License to Allow Production in Main Manufacturing Floor at its Jerusalem Site, Amended Radioactive License with Increased Capacity at Lawrence, MA Site
$Day One Biopharmaceuticals(DAWN.US$
- Co on Sunday Announced Results of Relaps...
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg